Last10K.com

Edge Therapeutics, Inc. (EDGE) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Edge Therapeutics, Inc.

HISTORY TOOLS
CIK: 1472091 Ticker: EDGE

View differences made from one to another to evaluate Edge Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Edge Therapeutics, Inc..

Continue

Assess how Edge Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Edge Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: EDGE
CIK: 1472091
Form Type: 8-K Corporate News
Accession Number: 0001140361-19-004622
Submitted to the SEC: Fri Mar 08 2019 5:19:07 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Tuesday, March 5, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/edge/0001140361-19-004622.htm